Navigation Links
Why chemotherapy fails
Date:5/29/2012

The fight against cancer is not won in a single battle: Long after a cancer has been beaten into remission, it can return. The reason for this is under debate, and much is unclear. New research led by Weizmann Institute scientists shows that, at least for one type of blood cancer, the source of cancer recurrence is in a set of cells that do not proliferate as quickly as regular cancer cells, and thus able to survive chemotherapy. The findings, which appeared today in the journal Blood, have some important implications for the future of the war on cancer.

Cancer involves a breakdown in the mechanism that regulates the pace of cell division. When this happens, cells divide rapidly, leading to unchecked growth that overruns the body. The most common chemotherapy drugs are those which specifically attack cells that are undergoing rapid division, and these, indeed, often destroy all the cancer and cure the patient.

But there are also quite a few leukemia patients who go through chemotherapy only to have the cancer return. Why does this happen? Several explanations have been proposed. One is that the chemotherapy does not kill every last cancer cell, leaving a few to continue dividing out of control until the disease returns in full force. A second explanation proposes that chemotherapy does get all the regular cancer cells, but there is another type of cancer cell that hides in the body. As opposed to the rapidly dividing majority of cancer cells, these undergo slow division, enabling them to evade the chemotherapy drugs. These insidious cells can give rise to new rapidly-dividing cancer cells, which is why they are known as "cancer stem cells."

Which explanation is correct? The debate is an important one because, if the first explanation holds true, improving upon the existing treatments might help, while the second implies that a completely different approach to treatment will be needed to root out the slowly dividing cancer ste
'/>"/>

Contact: Yivsam Azgad
news@weizmann.ac.il
972-893-43856
Weizmann Institute of Science
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Breast MRI helps predict chemotherapys effectiveness
2. Accelerated chemotherapy given before surgery benefits patients with muscle-invasive bladder cancer
3. Chemotherapys effect on overall survival seems to increase based on tumor size
4. Genetic predictor of breast cancer response to chemotherapy
5. Adding drug to standard chemotherapy provides no survival benefit for older lung cancer patients
6. Chemotherapy proves life-saving for some leukemia patients who fail induction therapy
7. Progress toward new chemotherapy agents
8. New genomic test spares patients chemotherapy with no adverse effect on survival
9. How chemotherapy becomes more effective
10. First study on long-term cognitive effects of breast cancer chemotherapy finds subtle impairment among women who received CMF regimen
11. Aurora-A hinders tumor-suppressor to allow chemotherapy resistance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... researchers in Taiwan has developed a new optical technology ... of diabetes sooner, when it is more easily treated. ... trials, it may pave the way for the early ... diabetic autonomic neuropathy, which is common among people with ... progressively affects the autonomic nerves controlling vital organs like ...
(Date:7/28/2014)... (PRWEB) July 28, 2014 Top Northridge ... coupon for new patients. Finding a new dentist can be ... dental issues that have gone untreated and worry about how ... Ariz specializes in patients with special concerns and dental needs ... comfortable and right at home. This special coupon can help ...
(Date:7/28/2014)... July 28, 2014 "I injured my shoulder ... said an inventor from Sunnyvale, Calif. "When I slept in ... the market are cumbersome and require too many straps. That ... developed the Multiple Functioning Vest to improve the design of ... so that they heal properly. This helps to speed up ...
(Date:7/28/2014)... HealthDay Reporter FRIDAY, July ... health insurance this year will face fines of up to ... the Internal Revenue Service says. The Obama administration on ... that some Americans will owe for failing to have health ... monthly national average premium for a bronze-level health plan. ...
(Date:7/28/2014)... 2014 Glidewell Laboratories announced today that ... successfully passed the five-year mark in clinical usage, and ... units prescribed by US dentists. , Even as BruxZir ... good results from respected clinical studies, many dentists expressed ... over extended years of clinical service before they would ...
Breaking Medicine News(10 mins):Health News:Wearable device for the early detection of common diabetes-related neurological condition 2Health News:Northridge Dentist, Dr. Farshid Ariz, is Now Offering a $100 Coupon for New Patients 2Health News:IRS Caps Fines on Uninsured Americans at $12K for Family of 5 2Health News:BruxZir® Solid Zirconia Surpasses Five Years of Clinical Use 2
... , HARRISBURG, Pa. , Jan. 13 ... launch of an innovative initiative to create clinically proven, ... of care for patients.  The P4 Pathways Program will ... for the treatment of patients with cancer, as well ...
... , NEW YORK , Jan. 13 ... been named president and CEO of Siemens Corporation. Spiegel, an ... on January 18 . , (Logo:   http://www.newscom.com/cgi-bin/prnh/20070904/SIEMENSLOGO ... Senior Partner at Booz & Co. and brings more than ...
... Bradley C. Brennecke , a resident of Pleasant Plain, Ohio ... , pleaded guilty late Tuesday to conspiracy and tax evasion charges before District ... Department and Internal Revenue Service (IRS) announced. , Mrusek and Brennecke, who ... icted in July 2009 and charged with tax ...
... in the general population use the drug responsibly, study finds ... taking Viagra will lead to sexually risky behavior can relax: ... make men more likely to engage in potentially unhealthy sex. ... a doctor who may worry that prescribing erectile-dysfunction drugs to ...
... say researchers working with mice , WEDNESDAY, Jan. 13 ... greater understanding of how a brain becomes susceptible to ... some people are resistant to antidepressants. , Scientists think ... -- cause the mental disorders. Antidepressants (such as Prozac) ...
... aged 6-19 still climbing, government study finds , WEDNESDAY, Jan. ... on weight: Obesity in the United States may finally be ... the rates of obesity remain high, with about one-third of ... obesity among already heavy 6- to 19-year-old boys appear to ...
Cached Medicine News:Health News:Capital BlueCross and P4 Healthcare Launch Cancer Pathways Initiative 2Health News:Capital BlueCross and P4 Healthcare Launch Cancer Pathways Initiative 3Health News:Capital BlueCross and P4 Healthcare Launch Cancer Pathways Initiative 4Health News:Siemens Taps Top Energy Expert as New Head of U.S. Business 2Health News:Siemens Taps Top Energy Expert as New Head of U.S. Business 3Health News:Two Cincinnati Dentists Plead Guilty to Conspiracy, Tax Evasion on Eve of Trial 2Health News:Taking Viagra Won't Spur Risky Sexual Behavior 2Health News: U.S. Obesity Rates Leveling Off, But Still High 2Health News: U.S. Obesity Rates Leveling Off, But Still High 3
(Date:7/28/2014)... INCLINE VILLAGE, Nev. , July 28, 2014 ... announced that the Company will release its second quarter 2014 ... Monday, August 11, 2014, after market close. PDL,s management will ... p.m. Eastern Time to discuss the financial results.  A slide ... webcast link on the PDL website. Conference Call ...
(Date:7/28/2014)... , Germany and ... , Collaboration aims to create and ... to guide the use of IRESSA  for non-small cell ... build on QIAGEN,s FDA-approved  therascreen   EGFR test and is ... of automated instruments  Project enabled by AstraZeneca ...
(Date:7/25/2014)... HILL, N.C. , July 25, 2014  Corporate ... challenges, including understanding new advancements in technology and how ... of this, libraries in the pharmaceutical and medical device ... value of the information and services they provide. ... Best Practices, LLC there are many forces of change ...
Breaking Medicine Technology:PDL BioPharma to Announce Second Quarter 2014 Financial Results on August 11, 2014 2QIAGEN and AstraZeneca Collaborate to Develop Liquid Biopsy-Based Companion Diagnostic to Advance EGFR Mutation Profiling in Lung Cancer Patients 2QIAGEN and AstraZeneca Collaborate to Develop Liquid Biopsy-Based Companion Diagnostic to Advance EGFR Mutation Profiling in Lung Cancer Patients 3QIAGEN and AstraZeneca Collaborate to Develop Liquid Biopsy-Based Companion Diagnostic to Advance EGFR Mutation Profiling in Lung Cancer Patients 4QIAGEN and AstraZeneca Collaborate to Develop Liquid Biopsy-Based Companion Diagnostic to Advance EGFR Mutation Profiling in Lung Cancer Patients 5QIAGEN and AstraZeneca Collaborate to Develop Liquid Biopsy-Based Companion Diagnostic to Advance EGFR Mutation Profiling in Lung Cancer Patients 6Forces of Change Reshaping Corporate Libraries & Information Services 2
... , PHILADELPHIA, Oct. 20 Premier Research ... company, announces the appointment of Bernard Sweeney as Executive ... play a leading role in the operations, strategic planning, ... medical device business. He will be based in Premier ...
... N.J., Oct. 20 Cambrex Corporation (NYSE: CBM ... Award at the 2009 CPhI Event for its Continuous-Flow ... accepted by Dr. Jayne E. Muir (Market Research & ... a panel of judges at this important pharmaceutical ingredients ...
Cached Medicine Technology:Premier Research Names Bernard Sweeney as Executive Director, Medical Devices 2Cambrex Continuous-Flow Microwave-Assisted Organic Synthesis Technology Wins 2009 Silver Innovation Award 2
Duckbill. 3.5 mm tip. Light curve....
4 mm x 9 mm tip....
6 mm wide tip. Gentle tapered blade. Designated most popular model or size....
9 mm wide tip. 35 mm from angle to tip....
Medicine Products: